3 Questions with Emily Levy, Mighty Well “3 Questions With…” is a video series showcasing thought leaders in healthcare specialties like Infection Prevention and Vascular Access. These experts provide insights, evidence, and best practices in response to pressing questions in their fields. Eloquest Healthcare is proud to feature 3 Questions with Emily Levy, Mighty Well.…
Swapna Kakani was diagnosed at birth with a rare chronic disease, Short Bowel Syndrome. For 27 years, Swapna has lived with supplemental intravenous nutrition and a feeding tube (from 0-24 she had a gastrostomy tube and from 24 onwards she has had an ileostomy). She has undergone several surgeries at multiple hospitals throughout the United…
Isabelle Edwards is known across the internet as the Diabetes Diva, and if you ever have the privilege of meeting her, you will understand why! Isabelle lives with Type 2 Diabetes, but her enthusiasm for life, her kindness, and her glamour are what you remember after spending time with her. She is a fierce advocate…
When Emily Levy was a sophomore in college, she was diagnosed with neurological Lyme disease and required a PICC to facilitate her treatment. This PICC was the first of many vascular access devices Emily has depended on and, unfortunately, Lyme was only the first of many diagnoses to come. Despite facing long term illness and…
Video Resources Procedural Videos Mastisol® Liquid Adhesive Vial Application Instructions Detachol® Adhesive Remover Vial Application Instructions SecurAcath® Instructional Video Adhesive Remover Comparison – Detachol vs. Wipe Gum Mastic: What is it and why do I need it for my vascular access dressings? Vascular Access Care & Maintenance: Avoid MARSI during Dressing Changes Modern Vascular Access…
As a tumultuous 2020 ends, we would like to thank you for being part of the Eloquest Healthcare Blog! We hope you have found our posts both informative and impactful to your professional career. We kicked off the year with an often overlooked topic – burnout in the Nursing profession. Remaining true as we close…